An algorithmic approach for the treatment of severe uncontrolled asthma

 
Eleftherios ZervasKonstantinos SamitasAndriana I. PapaioannouPetros BakakosStelios LoukidesMina Gaga

Abstract

A small subgroup of patients with asthma suffers from severe disease that is either partially controlled or uncontrolled despite intensive, guideline-based treatment. These patients have significantly impaired quality of life and although they constitute <5% of all asthma patients, they are responsible for more than half of asthma-related healthcare costs. Here, we review a definition for severe asthma and present all therapeutic options currently available for these severe asthma patients. Moreover, we suggest a specific algorithmic treatment approach for the management of severe, difficult-to-treat asthma based on specific phenotype characteristics and biomarkers. The diagnosis and management of severe asthma requires specialised experience, time and effort to comprehend the needs and expectations of each individual patient and incorporate those as well as his/her specific phenotype characteristics into the management planning. Although some new treatment options are currently available for these patients, there is still a need for further research into severe asthma and yet more treatment options.

Article
Figures & Data
Info & Metrics
 PDF

(You must be logged in to add and reply comments)

Interasma on Twitter

Interasma Top story: European Academy of Allergy and Clinical Immunology calls for improved food allergy labelling to protect… https://t.co/BoO5npfZel
3hreplyretweetfavorite
Interasma RT @Aller_MD: My Tweeted Times https://t.co/36WLWcQjoy - top stories by @DrLindaMD, @GavinPrestonMD
5hreplyretweetfavorite
Interasma RT @Aller_MD: Top story: Percentage of young U.S. children who don’t receive any vaccines has quadrupled since 2001 - The Washington Post h…
6hreplyretweetfavorite
Interasma RT @ProfGRoberts: European Academy of Allergy and Clinical Immunology calls for improved food allergy labelling to protect consumers with f…
6hreplyretweetfavorite

Editor: Juan C. Ivancevich, MD

Copyright © Interasma 2003-2017  •  Terms of Use  •  Privacy Policy  •  Contact Us  •  Sitemap

Powered by FREI SA

InterAsma